Accuray Incorporated (ARAY)
NASDAQ: ARAY · IEX Real-Time Price · USD
2.185
+0.005 (0.23%)
Apr 26, 2024, 10:35 AM EDT - Market open
Accuray Market Cap
Accuray has a market cap or net worth of $216.68 million as of April 26, 2024. Its market cap has decreased by -22.28% in one year.
Market Cap
216.68M
Enterprise Value
343.92M
1-Year Change
-22.28%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since February 8, 2007, Accuray's market cap has decreased from $1.40B to $216.68M, a decrease of -84.54%. That is a compound annual growth rate of -10.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 216.20M | -0.92% |
Apr 24, 2024 | 218.20M | -0.91% |
Apr 23, 2024 | 220.20M | 2.32% |
Apr 22, 2024 | 215.20M | 1.41% |
Apr 19, 2024 | 212.20M | -3.19% |
Apr 18, 2024 | 219.20M | 0.92% |
Apr 17, 2024 | 217.20M | -1.76% |
Apr 16, 2024 | 221.10M | -3.49% |
Apr 15, 2024 | 229.10M | 1.33% |
Apr 12, 2024 | 226.10M | -2.59% |
Apr 11, 2024 | 232.10M | -1.23% |
Apr 10, 2024 | 235.00M | -1.67% |
Apr 9, 2024 | 239.00M | 0.42% |
Apr 8, 2024 | 238.00M | - |
Apr 5, 2024 | 238.00M | -0.42% |
Apr 4, 2024 | 239.00M | 0.42% |
Apr 3, 2024 | 238.00M | -1.24% |
Apr 2, 2024 | 241.00M | 0.84% |
Apr 1, 2024 | 239.00M | -2.41% |
Mar 28, 2024 | 244.90M | 1.62% |
Mar 27, 2024 | 241.00M | 2.55% |
Mar 26, 2024 | 235.00M | -4.43% |
Mar 25, 2024 | 245.90M | -0.41% |
Mar 22, 2024 | 246.90M | -1.98% |
Mar 21, 2024 | 251.90M | -2.29% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
23andMe Holding Co. | 225.57M |
Ovid Therapeutics | 222.74M |
Foghorn Therapeutics | 221.77M |
AVITA Medical | 220.31M |
2seventy bio | 219.10M |
uniQure | 218.14M |
Adaptimmune Therapeutics | 217.36M |
X4 Pharmaceuticals | 216.64M |